Rabsig-IT Capsule PR
Marketer
Signova Pharma Pvt Ltd
Salt Composition
Rabeprazole (20mg) + Itopride (150mg)
Overview Rabsig-IT Capsule PR
Gastro-esophageal reflux disease (GERD) and peptic ulcers are effectively managed with the combined medication, Rabsig-IT Capsule PR. This formulation alleviates acidity symptoms, including heartburn, stomach upset, and irritation, by neutralizing stomach acid and facilitating gas expulsion. Dosage and duration are determined by your physician, considering your individual health status and response. Consistent use, as prescribed, is crucial; premature discontinuation may lead to symptom recurrence and condition exacerbation. Complete disclosure of all other medications to your healthcare provider is vital, as interactions are possible. Common, typically transient, side effects include abdominal pain, altered bowel habits (diarrhea or constipation), headache, gas, fatigue, and increased salivation. Report any concerning side effects immediately. Drowsiness and dizziness are potential effects; avoid activities requiring alertness until the medication's impact is understood. Alcohol consumption should be avoided due to potential additive drowsiness. Lifestyle adjustments, such as consuming cool milk and limiting hot beverages, spicy foods, and chocolate, can enhance treatment efficacy. Pre-existing liver conditions, pregnancy, planned pregnancy, or breastfeeding should be discussed with your doctor before initiating treatment with Rabsig-IT Capsule PR.
Primary Ingredients of Rabsig-IT Capsule PR
No text provided. Please provide the text you wish me to rephrase.
Uses of Rabsig-IT Capsule PR
Heartburn and ulcers (GERD and PUD)
Major Benefits of Rabsig-IT Capsule PR:
Follow your doctor's instructions or consult the product label for usage guidance. Take Rabsig-IT Capsule PR on an empty stomach.
Common Side effects of Rabsig-IT Capsule PR:
- Stomach pain
- Diarrhea
- Constipation
- Headache
- Dizziness
- Flatulence
- Weakness
- Flu-like symptoms
- Increased saliva production
- Insomnia (difficulty in sleeping)
- Back pain
How to use Rabsig-IT Capsule PR:
Follow your physician's instructions or consult the product label for usage guidelines. Take Rabsig-IT Capsule PR on an empty stomach.
How Rabsig-IT Capsule PR works:
Rabsig-IT Capsule PR combines rabeprazole, a proton pump inhibitor (PPI), and itopride, a prokinetic agent. Rabeprazole diminishes stomach acid production, alleviating acid indigestion and heartburn. Itopride, by influencing the brain's vomiting center and enhancing upper gastrointestinal motility, facilitates smoother food passage through the digestive system.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Rabsig-IT Capsule PR and alcohol. Seek medical advice before doing so.
PregnancyCONSULT YOUR DOCTOR
The use of Rabsig-IT Capsule PR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing it. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Rabsig-IT Capsule PR usage while breastfeeding is absent. Seek your physician's advice.
DrivingUNSAFE
Driving may be impaired by Rabsig-IT Capsule PR, which can cause drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Rabsig-IT Capsule PR efficacy and safety in individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Rabsig-IT Capsule PR cautiously, potentially requiring dosage modification. Physician consultation is advised.
What if you forget to take Rabsig-IT Capsule PR :
Should you forget a Rabsig-IT Capsule PR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Rabsig-IT Capsule PR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |


